In a world first, medical regulators in the UK have approved a gene therapy that aims to cure sickle cell disease and beta thalassemia.
The treatment is the first to be licensed using the gene-editing tool known as Crispr, for which its discoverers were awarded the Nobel prize in 2020.
It is a revolutionary advance for two inherited blood conditions, both triggered by errors in the gene for haemoglobin.
In trials, 28 out of 29 sickle cell patients were free of severe pain and 39 of 42 beta thalassemia patients no longer needed blood transfusions for at least a year.
The trials are continuing in the UK, US, France, Germany and Italy.
Please subscribe here: http://bit.ly/1rbfUog
#GeneTherapy #SickleCellDisease #BetaThalassemia #BBCNews
Today, Laura, Paddy and Henry discuss whether Iranian missiles could feasibly strike the UK, as Israel has claimed. The Israeli…
GOIANIA (BRASILE) (ITALPRESS) – Marco Bezzecchi, in sella all’Aprilia, bissa il successo dell’esordio in Thailandia, vincendo anche la gara lunga…
ROMA (ITALPRESS) – Un mese esatto dopo l’ultima volta, la Roma torna a vincere in campionato. In un Olimpico ferito…
PALERMO (ITALPRESS) – Il presidente della Repubblica Sergio Mattarella ha votato per il referendum sulla giustizia questa mattina a Palermo,…
TRAPANI (ITALPRESS) – Nella tarda mattinata di oggi, il Soccorso Alpino e Speleologico Siciliano è intervenuto sul Monte Pispisa, nel…